Xzom, Inc.

A liquid biopsy company pioneering a rapid, point-of-care diagnostic platform powered by exosome analysis that delivers accurate, sample-to-answer results in under 30 minutes. By enabling earlier detection and faster clinical decision-making, our platform has the potential to significantly improve p... Read more